Russell Investments Group
MCRB icon

Russell Investments Group’s Seres Therapeutics MCRB Stock Holding History

Russell Investments Group’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-915
Closed -$17.3K – 3758
2024
Q3 		$17.3K Sell
915
-185
-17% -$3.75K ﹤0.01% 2988
2024
Q2 		$15.9K Buy
1,100
+185
+20% +$3.09K ﹤0.01% 2979
2024
Q1 		$14.2K Hold
915
– – ﹤0.01% 2811
2023
Q4 		$25.6K Hold
915
– – ﹤0.01% 2715
2023
Q3 		$43.6K Hold
915
– – ﹤0.01% 2773
2023
Q2 		$87.7K Hold
915
– – ﹤0.01% 2631
2023
Q1 		$104K Hold
915
– – ﹤0.01% 2582
2022
Q4 		$102K Hold
915
– – ﹤0.01% 2670
2022
Q3 		$117K Sell
915
-2,350
-72% -$241K ﹤0.01% 2645
2022
Q2 		$222K Sell
3,265
-284
-8% -$24.5K ﹤0.01% 2517
2022
Q1 		$504K Sell
3,549
-1,157
-25% -$178K ﹤0.01% 2222
2021
Q4 		$782K Buy
4,706
+3,791
+414% +$602K ﹤0.01% 2271
2021
Q3 		$127K Hold
915
– – ﹤0.01% 2852
2021
Q2 		$436K Hold
915
– – ﹤0.01% 2651
2021
Q1 		$376K Buy
915
+439
+92% +$202K ﹤0.01% 2634
2020
Q4 		$233K Buy
+476
New +$279K ﹤0.01% 2717
2020
Q3 		– Sell
-3,702
Closed -$352K – 3226
2020
Q2 		$352K Buy
3,702
+535
+17% +$46.9K ﹤0.01% 2518
2020
Q1 		$225K Buy
3,167
+219
+7% +$14.7K ﹤0.01% 2503
2019
Q4 		$202K Buy
+2,948
New +$219K ﹤0.01% 2710
2019
Q2 		– Sell
-1,230
Closed -$169K – 2917
2019
Q1 		$169K Buy
1,230
+120
+11% +$14.6K ﹤0.01% 2645
2018
Q4 		$101K Buy
+1,110
New +$155K ﹤0.01% 2726
2018
Q2 		– Sell
-580
Closed -$85K – 2930
2018
Q1 		$85K Buy
580
+85
+17% +$16.3K ﹤0.01% 2770
2017
Q4 		$102K Buy
+495
New +$102K ﹤0.01% 2771
2017
Q1 		– Sell
-186
Closed -$37K – 3038
2016
Q4 		$37K Buy
+186
New +$40.6K ﹤0.01% 3003

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's MCRB Position: Q4 2024 in Review

Russell Investments Group sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 915 shares — an estimated $17.3K sold.

Russell Investments Group first reported a position in MCRB in Q4 2016 and held it in 24 quarters. The position peaked at $782K in Q4 2021. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

  • Russell Investments Group reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 915 Seres Therapeutics shares in Q4 2024, an estimated $17.3K.
  • Russell Investments Group first reported a position in Seres Therapeutics in Q4 2016 and held it in 24 quarters.
  • Russell Investments Group's Seres Therapeutics position peaked at $782K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.